trial · primary record
Eptinezumab
Post Traumatic Headache
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-12-30 |
| Primary endpoint | Headache frequency |
| Registry ID | NCT07191145 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:57.413Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07191145
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.